Cargando…
Differential nm23 gene expression at the fetal-maternal interface.
The product of the nm23 gene has been proposed as a candidate tumour metastasis suppressor protein. A strong association has been observed between reduced expression of the nm23 gene and acquisition of metastatic behaviour in some tumour cells, including breast cancer and melanoma, but not in others...
Autores principales: | Shi, Y., Parhar, R. S., Zou, M., al-Sedairy, S., Farid, N. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033350/ https://www.ncbi.nlm.nih.gov/pubmed/8080727 |
Ejemplares similares
-
High levels of Nm23 gene expression in advanced stage of thyroid carcinomas.
por: Zou, M., et al.
Publicado: (1993) -
Differential Gene Expression at the Maternal-Fetal Interface in Preeclampsia Is Influenced by Gestational Age
por: Lian, Ingrid A., et al.
Publicado: (2013) -
Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
por: Shi, Y., et al.
Publicado: (1996) -
Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma: correlation with tumour progression and nm23 gene expression.
por: Mandai, M., et al.
Publicado: (1995) -
Expression of anti-metastatic gene nm23.
por: Hennessy, C., et al.
Publicado: (1991)